Slingshot members are tracking this corporate initiative:
Allergan Acquires Topical Dermatology Company Topokine Therapeutics Adding Non-Invasive Fat Reduction Development Program
Do you think this event is important to the companies below? How will it affect their stock price?
-- XAF5 currently being studied in phase 2b/3 pivotal trial --
-- Adds to Allergan's robust mid-to-late stage pipeline, reinforces leadership in aesthetics innovation --
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Apr 21, 2016 Projected Implementation: Q2, 2016 Relevance Tracked Until: Q3, 2016
Don’t see a project related to the strategic initiative you care about?
Related Keywords Non-invasive Fat Reduction, Xaf5, Steatoblepharon